Bruker expects FY 2026 non-GAAP EPS of $2.10-$2.15 while targeting 250-300 bps operating margin expansion (NASDAQ:BRKR)
Bruker (BRKR) anticipates FY 2026 non-GAAP EPS of $2.10-$2.15 and a 250-300 bps operating margin expansion. CEO Frank Laukien reported five consecutive quarters of BSI book-to-bill over 1, with strong U.S. academic/government market bookings.
How this was made
The 30-second read
Why it matters
The FY 2026 guidance provides the first quantitative outlook for earnings and margins, offering a clear catalyst for price movement.
Market read
New earnings guidance for a mid‑cap instrument maker; immediate relevance for equity traders and sector analysts.
What to watch
Margin expansion targets may signal operational improvements that could offset modest EPS growth.
Background
Bruker (NASDAQ:BRKR) reported continued strong bookings in its scientific instruments division, with book‑to‑bill >1 for five quarters.
Ticker impact
Bruker disclosed FY 2026 non‑GAAP EPS guidance of $2.10‑$2.15 and a 250‑300 bps operating margin expansion target.
potential downside as the market prices in modest EPS guidance versus prior expectations
Guidance is the first public disclosure of FY 2026 expectations; traders can act on the numbers immediately.
Market effects
Sets a benchmark for the scientific instruments sector's earnings outlook.
U.S. market participants will adjust exposure to Bruker ahead of the next trading session.
Limited to investors tracking precision‑instrument manufacturers.
Counterpoint
If the guidance exceeds consensus, the stock could rally despite modest numbers.
Key entities
- ExecutiveFrank Laukien
Chairman, CEO & President of Bruker who delivered the guidance.



